Presentation is loading. Please wait.

Presentation is loading. Please wait.

Rheumatology: Back to Basics: 2016

Similar presentations


Presentation on theme: "Rheumatology: Back to Basics: 2016"— Presentation transcript:

1 Rheumatology: Back to Basics: 2016
James Gillray “The Gout” 1799

2

3 Immune Mechanisms of Disease
Type I: Anaphylactic IgE eg. asthma Type II: Cytotoxic eg. AIHA Type III: Immune Complex eg. SLE Type IV: Cell-mediated/Delayed Hypersensitivity: T-cells eg. Contact dermatitis

4 GENETICS ENVIRONMENT Infections... AUTOIMMUNITY

5 HLA: Disease Associations
HLA B27 (MHC Class I) - Ankylosing Spondylitis Reiter’s/reactive arthritis - Psoriatic arthritis - IBD arthropathy HLA DR4, DR1 (MHC Class II) - RA HLA DR3 (MHC Class II) - SLE, Sjogren’s, Type I DM…

6 We love our antibodies...

7 Rheumatoid Factor Rheumatoid Arthritis: - sensitivity = 70%
Anti-antibodies (Fc domain of IgG) Rheumatoid Arthritis: - sensitivity = 70% - poor prognosis - extra-articular features Non-specific: - other rheumatic diseases eg. Sjogren’s - chronic inflammatory diseases - chronic infections – SBE, Hep C % over age 65

8 Anti-Citrullinated Peptide Antibodies (CCP or ACPA)
More specific for RA More sensitive than RF in early RA Associated with worse prognosis

9 Antinuclear Antibodies
Sensitivity for SLE 90%+ Specificity low - other autoimmune diseases - family members - drugs - ...

10 Raynaud’s phenomenon Cold, stress 3 phases: white blue  red
5 % of normals 90% - scleroderma Consider ANA when screening (SLE, CREST)

11 ANA: Anti-centromere pattern: Limited Systemic Sclerosis (CREST)

12 Other Autoantibodies Anti-DNA (native, double-stranded)
- SLE- sensitivity 60-70% - specificity ~ 100% - correlate with disease activity Anti-SSA, SSB (Ro, La) - Sjogren’s, SLE - congenital complete heart block

13 Antibodies to Ro/SSA 30-35% of patients with Lupus Associated with:
- Sjogren’s syndrome - photosensitive rashes “subacute cutaneous lupus” - Neonatal lupus - transient rashes - congenital complete heart block

14 Adult: Subacute Newborn: Cutaneous Lupus Neonatal Lupus
Antibodies to Ro/SSA Adult: Subacute Newborn: Cutaneous Lupus Neonatal Lupus

15 Antiphospholipid Antibodies
Anticardiolipin antibodies Lupus anticoagulant Anti -2 GPI Associations: - thrombosis - recurrent pregnancy losses SLE, other CTD’s, primary

16 Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
Patients with suspected vasculitis: - Granulomatosus with polyangiitis (GPA) Wegener’s - pulmonary/renal - RPGN - cocaine Cytoplasmic Perinuclear

17 Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
Patients with suspected vasculitis - pulmonary/renal syndromes cANCA: Granulomatosus with polyangiitis (GPA) Wegener’s: - 80% sensitive and specific - specificity is for PR-3 pANCA: less specific

18 Specific Diseases…

19 Osteoarthritis (OA) The most common type of arthritis
Disease of cartilage (cf. RA) Characterized by: - Cartilage degradation, loss - hypertrophic bone formation (osteophytes...

20 Primary (idiopathic) OA
Peripheral Joints: - hands - DIP, PIP (cf. RA) - 1st C-MC - feet - 1st MTP - large weight-bearing joints - hips, knees Spine - apophyseal joints - intervertebral discs

21 OA: Heberden’s (DIP) Bouchard’s (PIP) Nodes

22 Osteoarthritis: X-ray 1st C-MC Joint
Joint space narrowing Subchondral sclerosis Osteophytes

23 Rheumatoid Arthritis Prevalence 1:100
small joint, symmetric polyarthritis + AM stiffness chronic (>6weeks) Path = synovial inflammation Extra-articular features

24 DIPs  (spared) PIPs  MCPs 

25 Rheumatoid Arthritis Deformities Nodules Periarticular osteopenia
Marginal erosions

26 RA: Extra-articular Features
Skin - sc nodules, vasculitis... Eyes - sicca, scleritis, episcleritis Lungs - pleurisy/effusion - interstitial fibrosis - nodules Cardiac - pericarditis, nodules Hematologic - anemia, Felty’s (neutropenia…) Neurologic - peripheral neuropathy...

27 Scleritis

28 RA: Nodules

29 RA: Factors Associated with Poor Prognosis
RF, CRP, anti-CCP (ACPA) positivity HLA-DR4 haplotype Degree of disease activity at onset  Early aggressive therapy

30 RA: Treatment Symptomatic - rest, education - splints, orthotics
- ASA, NSAID’s, Coxibs Disease Modifying Anti-Rheumatic Drugs (DMARDs)

31 RA: Common DMARD’s Methotrexate Hydroxychloroquine Sulfasalazine
New Biologics...

32 RA: New Therapies - Biologics
anti-TNF soluble TNF receptor other mechanisms: CTLA4-Ig, IL-6, B-cells… Concerns: - cost - parenteral (most) - risk of infections, TB

33

34 Systemic Lupus Erythematosus
Affects 1: individuals African American blacks > Asian, hispanics, native NA > Caucasian Females : Males = 9:1 Any age - usually young females in their reproductive years

35 Lupus: Criteria Malar rash Hematology: Photosensitivity anti-WBC
Discoid rash Mucosal ulcers Arthritis Serositis “Pleurisy” Renal CNS Hematology: anti-WBC anti-platelet anti-rbc Immunologic: anti-DNA anti-phospholipid anti-Sm Antinuclear antibodies

36 SLE: Organs Affected Joints: 80-90% Skin: 70%, often photosensitive
Serositis: 50% Kidneys: 25-50% CNS: 15%

37 Discoid Lupus Plaques Photosensitive Often head & neck Scarring
10% develop SLE

38 Lupus: Treatment Sunscreens, sunprotection Anti-inflammatory drugs
Anti-malarial drugs Steroids Immunosuppressants Mycophenolate mofetil

39 Systemic Sclerosis (Scleroderma): Skin thickening, tightening

40 Scleroderma - small blood vessels = SPASM, ischemia +
Disorder of: - small blood vessels = SPASM, ischemia + - overproduction of connective tissue (collagen) = FIBROSIS

41 Scleroderma: Types Systemic - Diffuse
- Limited (CREST) anti-centromere Localized - morphea - linear scleroderma

42 Scleroderma Lungs - fibrosis - Pulmonary hypertension GI - GERD...
Renal - malignant hypertension - microangiopathic anemia - renal failure - ACE Inhibitors!!!!!!!!!!!!!!!

43 Limited Scleroderma (CREST)
Calcinosis Telangiectasias

44 Acute Monoarthritis (in absence of trauma)
Infection Crystal (gout, pseudogout) Spondyloarthropathy

45 Synovial Fluid Testing
Cell count, differential WBC: = non-inflammatory ,000 = inflammatory >75,000 = septic Gram stain, C&S Crystals

46 Spondyloarthropathies
Axial and/or peripheral joints HLA-B27 Path = enthesopathy Inflammatory back pain Extra-articular: - uveitis etc. RF negative Ankylosing Spondylitis Reiter’s/reactive arthritis Psoriatic arthritis Inflammatory Bowel Disease

47 Enthesitis Erosion Calcaneal Spur
Reiter’s - erosion at Achilles insertion into calcaneus and extra bone at site of plantar fasciitis Calcaneal Spur

48 Achilles tendinitis

49 Inflammatory low back pain?
Insidious onset Worse with rest Better with activity Morning stiffness Family history Bilateral Sacroiliitis

50 Ankylosing Spondylitis

51 HLA-B27: Disease Associations
Ankylosing Spondylitis >90% Reiter’s syndrome/ reactive 80% Inflammatory bowel disease 50% Psoriatic Arthritis - with spondylitis 50% - with peripheral arthritis 15% Caucasians % Inuit %

52 Reactive Arthritis: Concept
A sterile inflammatory arthritis - triggered by an infection - at a distant site (GI or GU) - in a genetically susceptible host

53 Bacteria that Trigger Reactive Arthritis
Post-venereal: Chlamydia trachomatis Post-dysenteric: Salmonella Shigella flexneri Yersinia enterocolitica Campylobacter Clostridium difficile

54 HLA-B27: Reactive Arthritis
Campylobacter

55 Spondyloarthropathies: Extra-articular features
Skin: Psoriasis, E. nodosum, pyoderma gangrenosum... Eyes: iritis, conjunctivitis Lungs: apical pulmonary fibrosis Cardiac: aortic insufficiency, conduction abnormalities Neurologic: cauda equina...

56

57 Reiter’s Syndrome

58 Gout Acute monoarthritis - lasts days - recurrent attacks Uncontrolled hyperuricemia  tophi  polyarthritis

59 Gout: uric acid crystals
Needle-shaped Strong negative bireringence Phagocytosed by PMN’s

60 Gout: Treatment Asymptomatic hyperuricemia  none
Acute attack - NSAID’s - colchicine - steroid’s Indications to lower uric acid – allopurinol, febuxistat - renal stones - frequent attacks - tophi

61 Pseudogout - CPPD Acute monoarthritis Knees, wrists Chondrocalcinosis
Pyrophosphate crystals: - rhomboid - weak positive birefringence

62 Vasculitis: Classification NB! can have overlap...
1. Large Vessel Vasculitis 2. Medium Vessel Vasculitis 3. Small Vessel Vasculitis

63 Large Vessel Vasculitis
- Giant Cell Arteritis - Takayasu’s (Aortic Arch Syndrome)

64 Medium Vessel Vasculitis
- Polyarteritis nodosa (PAN) - Kawasaki Disease - Primary CNS Vasculitis

65 Small Vessel Vasculitis
Palpable purpura Most common vasculitis Leukocytoclastic vasculitis Ag (eg. Infection, drug) + Ab  immune complex Rule out other organ involvement (kidney, lung…)

66 Small Vessel Vasculitis
- ANCA Associated: - Wegener Granulomatosis - Churg-Strauss Syndrome - Microscopic Polyangiitis (MPA) - Henoch-Schönlein Purpura (HSP) - Vasculitis with connective tissue diseases - Vasculitis/essential mixed cryoglobulinemia (Hep C) - Hypersensitivity vasculitis (leukocytoclastic) - Vasculitis with viral infections (Hep B, C, HIV, CMV, parvo-B19)

67 Small Vessel Vasculitis: ANCA associated: e.g. GPA Wegener’s
Small + medium vessels Granulomatous Upper +/- lower respiratory (ulcers, sinuses...) Renal

68 Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
Patients with suspected vasculitis: Pulmonary - renal: - GPA/Wegeners - ... Cytoplasmic Perinuclear

69 ANCA Immunofluorescence cytoplasmic - cANCA perinuclear - pANCA
Solid Phase Assays (ELISA…) : pANCA = anti-MPO (myeloperoxidase) cANCA = anti-PR3 (proteinase 3)

70 cANCA (anti-PR3) Highly sensitive, specific for Wegener’s granulomatosis Specificity: 95%

71 Large Vessel Vasculitis Giant Cell (Temporal) Arteritis

72 Large Vessel Vasculitis Giant Cell Arteritis (GCA)
Age >50 years - mean = 70 years Symptoms related to arteries: - headache, scalp tenderness - visual loss - jaw claudication

73 Giant Cell (Temporal) Arteritis
Diagnosis: - CBC - anemia of chronic disease - ESR - markedly elevated, often >100 - Biopsy temporal artery Treatment: URGENT! (prevent visual loss) - steroids - prednisone 60mg daily...

74 Fibromyalgia Prevalence 3% widespread pain, tender points
sleep disturbance Absence of inflammatory markers… Exclusion of other systemic disorders Treatment: - education - exercise - low dose tricyclic - New = pregabalin, duloxetine Canadian Guidelines

75

76 NSAIDs, Coxibs

77 Toxicity: ASA and NSAIDs
GI: ulcers, bleeding CVS: hypertension, increased risk MI, stroke Renal: Na retention, edema, renal failure CNS anti platelet effects contraindicated ASA hypersensitivity avoid if possible - pregnancy and lactation

78 Cox-2 “specific” Inhibitors (coxibs)
improved GI safety no effect on platelets efficacious in RA, OA, pain CVS, renal effects like other NSAID’s  caution! - elderly hypertension - cardiac disease - renal disease

79 The diaper is full so this must be…

80


Download ppt "Rheumatology: Back to Basics: 2016"

Similar presentations


Ads by Google